000 04408nam a22006375i 4500
001 978-1-0716-4374-7
003 DE-He213
005 20260610083719.0
007 cr nn 008mamaa
008 250129s2025 xxu| s |||| 0|eng d
020 _a9781071643747
_9978-1-0716-4374-7
024 7 _a10.1007/978-1-0716-4374-7
_2doi
050 4 _aRS199.5
072 7 _aTCB
_2bicssc
072 7 _aSCI010000
_2bisacsh
072 7 _aTCB
_2thema
082 0 4 _a615.6
_223
245 1 0 _aCancer-Targeted Drug Delivery
_h[electronic resource] /
_cedited by Ülo Langel.
250 _a1st ed. 2025.
264 1 _aNew York, NY :
_bSpringer US :
_bImprint: Humana,
_c2025.
300 _aXII, 232 p. 24 illus., 22 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
341 0 _bTable of contents navigation
_2onix
341 0 _bSingle logical reading order
_2onix
341 0 _bShort alternative textual descriptions
_2onix
341 0 _bUse of color is not sole means of conveying information
_2onix
341 0 _bUse of high contrast between text and background color
_2onix
341 0 _bNext / Previous structural navigation
_2onix
341 0 _bAll non-decorative content supports reading without sight
_2onix
347 _atext file
_bPDF
_2rda
490 1 _aMethods in Pharmacology and Toxicology,
_x1940-6053
505 0 _aApplication of Graphene Oxide in Tumor Targeting and Tumor Therapy -- Antitumoral Effect on Liver Cancer of a Tumor Penetrating and Interfering Peptide -- Computer-Aided Design for Cancer-Targeted Peptide Drugs -- Advances in the Manufacturing of CAR-NK Cells for Cancer Immunotherapy -- Addressing the Blood-Brain Barrier: Overcoming Glioblastoma Drug Delivery -- Advances in Cancer Gene Therapy: Strategies, Delivery Methods, and Challenges -- Targeted Tumor Delivery Using Extracellular Vesicles -- Peptide-Assisted CRISPR/Cas9 Delivery to Tumors -- Identification of Organ- and Disease-Specific Homing Peptides Using In Vivo Peptide Phage Display -- Cancer Vaccines.
520 _aThis detailed volume explores the frontiers of tumor targeting approaches in the field of tumor-targeted drug delivery and cancer therapy. Several topics involve the improvement of cancer detection and treatment using nanotechnologies, where the main challenge to transition from the laboratory to the clinic, with more effective, targeted, and less invasive treatments. Written for the Methods in Pharmacology and Toxicology series, chapters provide the kind of detailed implementation advice needed for successful future studies. Authoritative and innovative, Cancer-Targeted Drug Delivery serves as the ideal reference for researchers using current cutting-edge technologies for tumor-targeting of drugs.
532 8 _aAccessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com.
532 8 _aNo reading system accessibility options actively disabled
532 8 _aPublisher contact for further accessibility information: accessibilitysupport@springernature.com
650 0 _aDrug delivery systems.
650 0 _aCancer
_xTreatment.
650 0 _aCancer.
650 0 _aNanomedicine.
650 1 4 _aDrug Delivery.
650 2 4 _aCancer Therapy.
650 2 4 _aCancer Nanotechnology.
700 1 _aLangel, Ülo.
_eeditor.
_0(orcid)0000-0001-6107-0844
_1https://orcid.org/0000-0001-6107-0844
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9781071643730
776 0 8 _iPrinted edition:
_z9781071643754
776 0 8 _iPrinted edition:
_z9781071643761
830 0 _aMethods in Pharmacology and Toxicology,
_x1940-6053
856 4 0 _uhttps://doi.org/10.1007/978-1-0716-4374-7
912 _aZDB-2-PRO
999 _c8347
_d8347